Arintaya Phrommintikul

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Evaluation of Diffuse Myocardial Fibrosis in Heart Failure With Cardiac Magnetic Resonance Contrast-Enhanced T1 Mapping

L. Iles, Heinz Pflüger, Arintaya Phrommintikul et al. · Journal of the American College of Cardiology · 2008 · 738 citations

Cardiomyopathy, Heart Failure, Health Sciences +10

RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein Ardeschir Ghofrani, Gérald Simonneau, Andrea Maria D’Armini et al. · The Lancet Respiratory Medicine · 2017 · 262 citations

Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome

Arintaya Phrommintikul, Srun Kuanprasert, Wanwarang Wongcharoen et al. · European Heart Journal · 2011 · 241 citations

Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN‐HF Registry

Michael R. MacDonald, Wan Ting Tay, Tiew‐Hwa Katherine Teng et al. · Journal of the American Heart Association · 2019 · 114 citations · Full text